Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells

被引：0
|
作者：
Potenza, Alessia
Balestrieri, Chiara
Albarello, Luca
Pedica, Federica
Spiga, Martina
Manfredi, Francesco
Cianciotti, Beatrice C.
De lalla, Claudia
Stasi, Lorena
Tassi, Elena
Bonfiglio, Silvia
Scotti, Giulia M.
Redegalli, Miriam
Biancolini, Donatella
Abbati, Danilo
Simeoni, Fabio
Lazarevic, Dejan
Elmore, Ugo
Fiorentini, Guido
Di Lullo, Giulia
Casorati, Giulia
Doglioni, Claudio
Tonon, Giovanni
Dellabona, Paolo
Rosati, Riccardo
Aldrighetti, Luca
Ruggiero, Eliana
Bonini, Chiara
机构：
来源：
CANCER RESEARCH | 2023年 / 83卷 / 07期
关键词：
D O I：
10.1158/1538-7445.AM2023-902
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
902
引用
收藏
页数：3
相关论文
共 50 条
  • [11] Deletion of CD39 inhibits development of metastatic liver cancer
    Sun, Xiaofeng
    Wu, Yon
    Ogawa, Mika
    Enjoyi, Keiichi
    Csizmadia, Eva
    Beldi, Guido
    Robson, Simon C.
    HEPATOLOGY, 2007, 46 (04) : 690A - 690A
  • [12] Targeting CD39 in cancer
    Moesta, Achim K.
    Li, Xian-Yang
    Smyth, Mark J.
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (12) : 739 - 755
  • [13] Targeting CD39 in cancer
    Achim K. Moesta
    Xian-Yang Li
    Mark J. Smyth
    Nature Reviews Immunology, 2020, 20 : 739 - 755
  • [14] Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
    Kuenzli, Beat M.
    Bernlochner, Maria-Isabell
    Rath, Stephan
    Kaeser, Samuel
    Csizmadia, Eva
    Enjyoji, Keiichi
    Cowan, Peter
    d'Apice, Anthony
    Dwyer, Karen
    Rosenberg, Robert
    Perren, Aurel
    Friess, Helmut
    Maurer, Christoph A.
    Robson, Simon C.
    PURINERGIC SIGNALLING, 2011, 7 (02) : 231 - 241
  • [15] Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer
    Beat M. Künzli
    Maria-Isabell Bernlochner
    Stephan Rath
    Samuel Käser
    Eva Csizmadia
    Keiichi Enjyoji
    Peter Cowan
    Anthony d’Apice
    Karen Dwyer
    Robert Rosenberg
    Aurel Perren
    Helmut Friess
    Christoph A. Maurer
    Simon C. Robson
    Purinergic Signalling, 2011, 7 : 231 - 241
  • [16] Immune-regulation of CD39 on Regulatory T cells
    Siddiqui, Shafiuddin
    Da Cunha, Andre Pires
    Weiner, Howard L.
    JOURNAL OF NEUROIMMUNOLOGY, 2012, 253 (1-2) : 165 - 166
  • [17] CD39 Contributes to the Ability of Cell Invasion in Heterogeneity of Colorectal Cancer
    Li, Xiaosong
    Shen, Yifen
    Lang, Jianhua
    Wu, Jianzhong
    Qian, Zhenhai
    Shen, Genhai
    Shen, Yihang
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2025, 29 (05)
  • [18] Role of CD39 in proliferation, activation and cytotoxicity of CD8+T cells in ovarian cancer
    Witt, M.
    Brauneck, F.
    Ferrer, Oliveira L.
    Koch-Nolte, F.
    Sturmheit, T.
    Bokemeyer, C.
    Fiedler, W.
    Wellbrock, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 151 - 151
  • [19] CD39 promoting MDSC infiltration and remodeling of bone metastases in breast cancer
    Ni, X.
    BREAST, 2019, 44 : S89 - S90
  • [20] The Role of CD39 in Ovarian Cancer
    Brauneck, F.
    Witt, M.
    Oliveira-Ferrer, L.
    Sturmheit, T.
    Bokemeyer, C.
    Menzel, S.
    Fiedler, W.
    Wellbrock, J.
    ONCOLOGY RESEARCH AND TREATMENT, 2022, 45 (SUPPL 2) : 72 - 72
12345